Bio-Techne Announces Paper Publication In Annals Of Oncology

MINNEAPOLIS, Feb. 11, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has recently published a paper entitled Exosome-based Liquid Biopsies in Cancer: Opportunities and Challenges (Yu, W et al.), in the highly rated…

About the Author

has written 41608 stories on this site.

Copyright © 2010 Business and Corporate News.